Skip to main content

Table 2 Correlations between expression of receptors for BAFF and expression of markers for B and plasma cells, type I IFN production and plasmacytoid dendritic cells in muscle tissue a

From: Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies

  BAFF-Rb BCMAb TACIb CD19b CD138b
(n=15) (n=15) (n=15) (n=12) (n=12)
CD19b 0.49 0.44 0.19   
(n =12)
CD138b 0.70** 0.79*** 0.39 0.39  
(n =12)
MX-1c 0.23 0.33 0.38 0.12 −0.01
(n =15)
BDCA-2c 0.16 0.42 0.23 0.37 0.54*
(n =15)
  1. aBAFF-R, B-cell-activating factor of the tumour necrosis factor family receptor; BCMA, B-cell maturation antigen; BDCA-2, Blood dendritic cell antigen 2; MX-1, Interferon α/β–inducible myxovirus resistance 1 protein; TACI, Transmembrane activator and calcium modulator and cyclophilin ligand interactor. Data included to correlation analysis were: bNumbers of positive cells counted by conventional microscopy per area (n/mm2). Included samples which expressed at least one of the receptors. cQuantitative evaluation of expression by computerised image analysis (percentage of positively stained area). Data are correlation coefficients of Spearman’s rank order test. ***P <0.005, **P <0.01, *P <0.05, P <0.1.